Comparison of Generic (Rolexan) and Brand (Clexan) Forms of Enoxaparin in Critically Ill Patients: A Cross Over, Open Label, Randomized Prospective Clinical Trial

Backgrounds: Several generic forms of enoxaparin were introduced to the market after expiring the patent of Clexane. But the main problem with generic forms is its bio-equivalency with brand form as a little difference in active ingredients characteristics, could led to significant clinical differe...

Full description

Bibliographic Details
Main Authors: Shadi Ziaie, Hanieh Malekmohammadi, Mohammad Sistanizad
Format: Article
Language:English
Published: Research Center for Rational Use of Drugs (RCRUD) 2020-03-01
Series:Journal of Pharmaceutical Care
Subjects:
Online Access:https://jpc.tums.ac.ir/index.php/jpc/article/view/297

Similar Items